126 related articles for article (PubMed ID: 31913209)
1. Metformin Potential Impact on the Growth of Vestibular Schwannomas.
Feng AY; Enriquez-Marulanda A; Kouhi A; Ali NE; Moore JM; Vaisbuch Y
Otol Neurotol; 2020 Mar; 41(3):403-410. PubMed ID: 31913209
[TBL] [Abstract][Full Text] [Related]
2. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, Phase III trial and its pilot study.
Scheller C; Wienke A; Tatagiba M; Gharabaghi A; Ramina KF; Ganslandt O; Bischoff B; Zenk J; Engelhorn T; Matthies C; Westermaier T; Antoniadis G; Pedro MT; Rohde V; von Eckardstein K; Kretschmer T; Kornhuber M; Steighardt J; Richter M; Barker FG; Strauss C
J Neurosurg; 2017 Dec; 127(6):1376-1383. PubMed ID: 28298021
[TBL] [Abstract][Full Text] [Related]
4. Length of tumor-cochlear nerve contact and hearing outcome after surgery for vestibular schwannoma.
Yong RL; Westerberg BD; Dong C; Akagami R
J Neurosurg; 2008 Jan; 108(1):105-10. PubMed ID: 18173318
[TBL] [Abstract][Full Text] [Related]
5. Association of Metformin With Volumetric Tumor Growth of Sporadic Vestibular Schwannomas.
Armstrong MF; Lohse CM; Lees KA; Carlson ML
Otol Neurotol; 2021 Aug; 42(7):1081-1085. PubMed ID: 34260511
[TBL] [Abstract][Full Text] [Related]
6. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.
Golfinos JG; Hill TC; Rokosh R; Choudhry O; Shinseki M; Mansouri A; Friedmann DR; Thomas Roland J; Kondziolka D
J Neurosurg; 2016 Dec; 125(6):1472-1482. PubMed ID: 27035174
[TBL] [Abstract][Full Text] [Related]
7. Consequences to hearing during the conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors of Hearing Outcome in Untreated Vestibular Schwannomas: Implication of Subdivision of Their Growth by Volumetric Analysis.
Joo JD; Oh SJ; Kim YH; Han JH; Choi BY; Koo JW; Kim CY
World Neurosurg; 2017 Oct; 106():768-774. PubMed ID: 28751138
[TBL] [Abstract][Full Text] [Related]
10. The natural history of untreated vestibular schwannomas. Is there a role for conservative management?
Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
Rev Laryngol Otol Rhinol (Bord); 2000; 121(1):21-6. PubMed ID: 10865479
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of hearing preservation in untreated vestibular schwannomas.
Sughrue ME; Kane AJ; Kaur R; Barry JJ; Rutkowski MJ; Pitts LH; Cheung SW; Parsa AT
J Neurosurg; 2011 Feb; 114(2):381-5. PubMed ID: 20486891
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
14. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E32-E34. PubMed ID: 29309686
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Hearing Preservation Outcomes for Small Vestibular Schwannomas: Retrosigmoid Removal Versus Observation.
Zhu W; Chen H; Jia H; Chai Y; Yang J; Wang Z; Wu H
Otol Neurotol; 2018 Feb; 39(2):e158-e165. PubMed ID: 29315192
[TBL] [Abstract][Full Text] [Related]
16. Use of a flexible hollow-core carbon dioxide laser for microsurgical resection of vestibular schwannomas.
Schwartz MS; Lekovic GP
Neurosurg Focus; 2018 Mar; 44(3):E6. PubMed ID: 29490545
[TBL] [Abstract][Full Text] [Related]
17. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
19. Hearing preservation after intracanalicular vestibular schwannoma radiosurgery.
Niranjan A; Mathieu D; Flickinger JC; Kondziolka D; Lunsford LD
Neurosurgery; 2008 Dec; 63(6):1054-62; discussion 1062-3. PubMed ID: 19057318
[TBL] [Abstract][Full Text] [Related]
20. Middle Fossa Approach for Vestibular Schwannoma: Good Hearing and Facial Nerve Outcomes with Low Morbidity.
Raheja A; Bowers CA; MacDonald JD; Shelton C; Gurgel RK; Brimley C; Couldwell WT
World Neurosurg; 2016 Aug; 92():37-46. PubMed ID: 27150655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
